Development of serum models that can predict clinical outcomes in chronic liver disease

该项目的总体目标是开发能够准确预测慢性肝病患者肝脏相关死亡、肝癌和肝功能失代偿的血液检测。还将开发血液检查来预测非酒精性脂肪肝患者的心血管疾病。此外，我们将评估重复血液检测的使用，以评估与单个时间点相比，这是否可以更准确地预测死亡和并发症。

The overall objective of this project is to develop blood tests that can accurately predict liver related death, liver cancer and liver decompensation respectively for patients with chronic liver disease. Blood tests will also be developed to predict cardiovascular disease in patients with non-alcoholic fatty liver disease. Furthermore, we will evaluate the use of repeated blood tests to assess if this can more accurately predict death and complications compared to a single time point.